DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

Sarepta Therapeutics


company name or ticker

Why You Should Watch Amarin Corporation plc (ADR) and Sarepta Therapeutics Inc. Today

Biotech stocks on the move today.

Benzinga's Top #PreMarket Gainers

Why Sarepta Therapeutics, Rentrak, and Prosensa Are Today's 3 Best Stocks

Poor earnings from Best Buy drag down the S&P 500, while Sarepta Therapeutics, Rentrak, and Prosensa all soar by at least 24%!

Sarepta Therapeutics' CEO Presents at 32nd Annual J.P. Morgan Healthcare Conference (Transcript)

Will Sarepta Therapeutics Benefit From GlaxoSmithKline's Exit?

Glaxo's out of a drug partnership for a rare condition also targeted by a troubled drug from Sarepta. How will the exit impact Sarepta's future?

GSK Leaves Prosensa Hanging

GlaxoSmithKline hands back rights to DMD program to Prosensa, which could affect rival Sarepta Therapeutics.

Why Sarepta Therapeutics and Ariad Pharmaceuticals Fell

2014 isn't being kind to these two biopharmas.

This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind

UPDATE: Sarepta Downgraded by Citigroup on Eteplirsen Early Approval Setback

Morning Market Losers

See More Articles...